[4 cases of hyperplastic gingivitis during estroprogestational contraception].
D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004357:Drug Synergism; D004967:Estrogens / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005040:Ethynodiol Diacetate / Q000009:adverse effects; D005260:Female; D005891:Gingivitis / Q000139:chemically induced*; D006801:Humans; D008535:Megestrol / Q000009:adverse effects; D008656:Mestranol / Q000009:adverse effects; D009641:Norethynodrel / Q000009:adverse effects; D011372:Progestins / Q000009:adverse effects*
D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D008656:Mestranol; D008535:Megestrol
A propos de quatre cas de gingivite hyperplasique au décours de contraception par oestroprogestatif.